The American Society for Colposcopy and Cervical Pathology (ASCCP). Module 1: HPV Primary Screening.

The American Society for Colposcopy and Cervical Pathology (ASCCP)

Webinar.

Activity Summary:

Studies have shown that certain Human papillomavirus (HPV) types are a requisite for the development of cervical cancer and other cancers of the lower genital tract. The introduction of molecular testing for HPV has facilitated the earlier detection of cervical cancer precursors and identify those women at greatest risk of future disease. Today there are multiple methods of screening for cervical precancer and clear information is needed to sort out which tests offer the greatest opportunity to assure most women that they do not have disease risk, and identify those women early at risk of current and future cervical neoplasia.

This CME activity, Module 1, consists of a panel discussion exploring the availability of an FDA approved HPV test for primary, first line cervical cancer screening and how recently published interim guidance for primary screening fits with existing consensus cervical cancer screening and management guidelines. Panelists will discuss methods for testing cervical cancer, benefits of using cervical cytology and HPV testing, and integration of current screening recommendations with primary HPV testing.

Audience:

This activity is intended for clinicians from a variety of specialties including obstetrics and gynecology, family medicine and, internal medicine, for residents in obstetrics/gynecology and family medicine, for advanced practice clinicians working in family planning and other community clinics, private offices and hospital settings, for pathologists who supervise residents and fellows, and for physicians with administrative responsibility for gynecology patients.

Learning Objectives:

Upon completion of the course, participants will:Understand the epidemiology of HPV and cervical neoplasia

• Understand consensus screening and management guidelines and the new guidance for primary HPV screening and how to apply them in a clinical setting
• Understand methods and rationale for screening women under age 30
• Understand important differences between the use of specific laboratory developed testing techniques and those that have undergone intense testing and validation and achieved FDA approval and licensing.

CME Information:

• ACCME Accreditation

The American Society for Colposcopy and Cervical Pathology (ASCCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

• Continuing Medical Education Credits

The American Society for Colposcopy and Cervical Pathology designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty/Disclosures:

• Edward J. Mayeaux, Jr, MD, DABFP, FAAFP
  ASCCP, President
  Professor and Chairman
  Department of Family and Preventive Medicine
  Professor of Obstetrics and Gynecology
  University of South Carolina School of Medicine
  Columbia, South Carolina
• Warner K, Huh, MD
  Professor
  Division of Gynecologic Oncology
  Department of Obstetrics and Gynecology
  University of Alabama, Birmingham
  Birmingham, Alabama
• David C. Wilbur, MD
  Director , Clinical Imaging in Pathology Massachusetts General Hospital
  Professor of Pathology
  Harvard Medical School
  Boston, Massachusetts

Moderator:

• Thomas C. Wright, Jr, MD
  Past President, ASCCP
  Professor Emeritus of Pathology and Cell Biology
  Columbia University Medical Center
  New York, New York